Locally advanced resectable larynx (L) or oropharynx (OP) cancer: Updated results of organ preservation trial ECOG 2399.

被引：0
|
作者：
Cmelak, A. J.
Li, S.
Murphy, B.
Burkey, B.
Adams, G. L.
Cannon, M.
Pinto, H.
Rosenthal, D. I.
Ridge, J. A.
Forastiere, A. A.
机构：
[1] Vanderbilt Ingram Canc Ctr, Nashville, TN USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[4] Univ Minnesota, Minneapolis, MN USA
[5] Canc Ctr Kansas, Wichita, KS USA
[6] Stanford Univ, Palo Alto, CA 94304 USA
[7] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
[8] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
[9] Johns Hopkins Univ, Baltimore, MD USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：286S / 286S
页数：1
相关论文
共 50 条
  • [21] Evaluation of Larynx Preservation on Patients with Locally Advanced Laryngeal Cancer in the Era of IMRT: Results from a Single Tertiary Cancer Center
    Song, J.
    Yegendorf, D.
    Eapen, L.
    El-Sayed, S.
    Gaudet, M.
    Haddad, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E233 - E233
  • [22] Taxane-based chemoirradiation for organ preservation with locally advanced head and neck cancer: Results of a phase II multi-institutional trial
    Cmelak, Anthony J.
    Murphy, Barbara A.
    Burkey, Brian
    Douglas, Stacy
    Shyr, Yu
    Netterville, James
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2007, 29 (04): : 315 - 324
  • [23] Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311)
    Ferris, Robert L.
    Flamand, Yael
    Weinstein, Gregory S.
    Li, Shuli
    Quon, Harry
    Mehra, Ranee
    Garcia, Joaquin J.
    Chung, Christine H.
    Gillison, Maura L.
    Duvvuri, Umamaheswar
    O'Malley, Bert W., Jr.
    Ozer, Enver
    Thomas, Giovana R.
    Koch, Wayne M.
    Gross, Neil D.
    Bell, R. Bryan
    Saba, Nabil F.
    Lango, Miriam
    Mendez, Eduardo
    Burtness, Barbara
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (02) : 138 - +
  • [24] Neoadjuvant cetuximab, capecitabine, and radiotherapy (RT) in locally advanced resectable rectal cancer: results of a phase II trial
    Velenik, V.
    Ocvirk, J.
    Oblak, I.
    Anderluh, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [25] Neo-adjuvant (primary) organ preserving chemotherapy in the management of locally advanced oral cavity and oropharynx cancer: A temptative quantitative evaluation of organ preservation and clinical response
    Curreli, L
    Bianchi, A
    Ghiani, M
    Astara, G
    Lampis, B
    Proto, E
    Cossu, F
    Gebbia, V
    Mantovani, G
    10TH MEDITERRANEAN CONGRESS OF CHEMOTHERAPY, 1996, : 473 - 478
  • [26] Neo-adjuvant organ-preserving chemotherapy in the management of locally advanced oral cavity and oropharynx cancer: A tentative quantitative evaluation of organ preservation and clinical response
    Mantovani, G
    Gebbia, V
    Proto, E
    Cossu, F
    Bianchi, A
    Curreli, L
    Ghiani, M
    Astara, G
    Lampis, B
    Dessi, D
    Santona, MC
    Massa, E
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1996, 9 (03) : 571 - 578
  • [27] Developing Consensus Pathway for Total Neoadjuvant Therapy (TNT)/Organ Preservation (OP) in Locally Advanced Rectal Cancer (LARC): Practical Considerations
    Jain, Ankit
    Shorthouse, Amy
    Rangiah, David
    Geoffrey, Peters
    Prasanna, Thiru
    Chua, Yu Jo
    Pulverenti, Trish
    Ganesalingam, Ram
    Azmir, Alisha
    Singh, Neha
    Tamhane, Rohit
    Mitali, Fadia
    Trevaskis, Catherine
    Hayes, Tanya
    Syed, Farhan
    Yip, Desmond
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2024, 20 : 18 - 18
  • [28] PRELIMINARY RESULTS OF A PHASE II CLINICAL TRIAL: TOTAL NEOADJUVANT THERAPY FACILITATES ORGAN PRESERVATION FOR PATIENTS DIAGNOSED WITH LOCALLY ADVANCED RECTAL CANCER.
    Abdalla, A.
    Aref, A.
    Alame, A.
    Barawi, M.
    Ma, D.
    Mazzara, P.
    Szpunar, S.
    Kafri, Z.
    DISEASES OF THE COLON & RECTUM, 2019, 62 (06) : E284 - E284
  • [29] Transoral robotic surgical resection followed by randomization to low- or standard-dose IMRT in resectable p16+locally advanced oropharynx cancer: A trial of the ECOG-ACRIN Cancer Research Group (E3311).
    Ferris, Robert L.
    Flamand, Yael
    Weinstein, Gregory S.
    Li, Shuli
    Quon, Harry
    Mehra, Ranee
    Garcia, Joaquin J.
    Chung, Christine H.
    Gillison, Maura L.
    Duvvuri, Umamaheswar
    O'malley, Bert W.
    Ozer, Enver
    Thomas, Giovana R.
    Koch, Wayne
    Kupferman, Michael Elliot
    Bell, Richard Bryan
    Saba, Nabil F.
    Lango, Miriam
    Mendez, Eduardo
    Burtness, Barbara
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [30] Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal/hypopharyngeal cancer resectable only by total laryngectomy-final results of the larynx organ preservation trial DeLOS-II
    Dietz, A.
    Wichmann, G.
    Kuhnt, T.
    Pfreundner, L.
    Hagen, R.
    Scheich, M.
    Koelbl, O.
    Hautmann, M. G.
    Strutz, J.
    Schreiber, F.
    Bockmuehl, U.
    Schilling, V.
    Feyer, P.
    de Wit, M.
    Maschmeyer, G.
    Jungehuelsing, M.
    Schroeder, U.
    Wollenberg, B.
    Sittel, C.
    Muenter, M.
    Lenarz, T.
    Klussmann, J. P.
    Guntinas-Lichius, O.
    Rudack, C.
    Eich, H. T.
    Foerg, T.
    Preyer, S.
    Westhofen, M.
    Welkoborsky, H. J.
    Esser, D.
    Thurnher, D.
    Remmert, S.
    Sudhoff, H.
    Goerner, M.
    Buenzel, J.
    Budach, V.
    Held, S.
    Knoedler, M.
    Lordick, F.
    Wiegand, S.
    Vogel, K.
    Boehm, A.
    Flentje, M.
    Keilholz, U.
    ANNALS OF ONCOLOGY, 2018, 29 (10) : 2105 - 2114
12345